Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001641172-25-018489
Filing Date
2025-07-09
Accepted
2025-07-09 18:37:33
Documents
1
Period of Report
2025-07-03

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 4234
  Complete submission text file 0001641172-25-018489.txt   5732
Mailing Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733
Business Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733 310 203 2902
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Issuer) CIK: 0001335105 (see all company filings)

EIN.: 202903526 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 412 E BOCA RATON ROAD BOCA RATON FL 33432
Business Address
Pursglove Geordan Garrett (Reporting) CIK: 0002073519 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39717 | Film No.: 251114531